This public procurement contract is for the supply of a genetic analyzer specifically designed for Sanger sequencing and fragment analysis. It includes the provision of related consumables as specified in the relevant appendices of the tender documentation. Suppliers are invited to submit their prop
Tender closed on 29 Dec 2025. Awaiting award.
This public procurement contract involves the supply of medicinal products as specified in the attached documents. The contract is divided into five parts according to the specifications provided in the documentation. Suppliers are invited to submit their offers based on the detailed requirements ou
This public procurement contract involves the supply of a theragnostic application system, including necessary accessories and related consumables as specified in Appendix 2 of the tender documentation (contract templates). Additionally, it includes the provision of related supplies and services as
This public procurement contract involves the supply of a medicinal product, specifically Fludeoxyglucose-(18F), as detailed in the specifications and conditions outlined in attachments 2 (Public Procurement Specifications) and 3 (Sample Purchase Agreement) of the tender documentation. The contract
This public procurement contract is for the supply of scanners necessary for the complete digitization of the biopsy operations at the Oncology Pathology Department of the contracting authority. The specifications and conditions are outlined in Appendix 2 of the tender documentation (contract templa
UK-based astronomy observers can apply for travel and subsistence grants of up to £15,000 over two years to visit facilities with competitively awarded observation time.
UK biomedical researchers can apply for up to £1 million in MRC funding to purchase a single piece of mid-range capital equipment by 31 December 2027.
NERC invites qualified researchers to apply for large grants (£1.12-£3.45 million) for innovative environmental science projects lasting up to five years.
UKRI is offering up to £60 million over seven years for a director-led research institute to investigate obesity and cardiometabolic disease mechanisms with translation to prevention and treatment strategies.
